Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)

A. Jaureguizar Oriol (Madrid, Spain), E. Barbero Herranz (Madrid, Spain), C. Quezada Loaiza (Madrid, Spain), D. Barrios Barreto (Madrid, Spain), A. Román Broto (Barcelona, Spain), J. Segovia Cubero (Madrid, Spain), T. Elías Hernández (Sevilla, Spain), S. Cadenas Menéndez (Salamanca, Spain), P. Bedate Díaz (Asturias, Spain), I. Blanco Vich (Barcelona, Spain), P. Escribano Subías (Madrid, Spain)

Source: International Congress 2018 – Pulmonary hypertension: therapy
Session: Pulmonary hypertension: therapy
Session type: Thematic Poster
Number: 3044
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Jaureguizar Oriol (Madrid, Spain), E. Barbero Herranz (Madrid, Spain), C. Quezada Loaiza (Madrid, Spain), D. Barrios Barreto (Madrid, Spain), A. Román Broto (Barcelona, Spain), J. Segovia Cubero (Madrid, Spain), T. Elías Hernández (Sevilla, Spain), S. Cadenas Menéndez (Salamanca, Spain), P. Bedate Díaz (Asturias, Spain), I. Blanco Vich (Barcelona, Spain), P. Escribano Subías (Madrid, Spain). Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP). 3044

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: